Work

Evaluation of kidney function at ICU discharge using iohexol clearance in patients with normal serum creatinine after acute kidney injury

Year: 2026
Type: article
Study design: Observational Study
Abstract: Acute kidney injury (AKI) is a common complication in critically ill patients and is associated with high rates of mortality or progression to chronic kidney disease, even when serum creatinine returns to normal at ICU discharge. This study aims to evaluate the frequency of non-resolving kidney dysfunction at ICU discharge despite normal serum creatinine levels following AKI, and to assess its association with chronic kidney disease at 6 months. This multicenter, observational study included patients who experienced AKI (KDIGO stage 2 or 3) during their ICU stay and had serum creatinine < 130 µmol/L (men) or <110 µmol/L (women) at discharge. Iohexol clearance and serum and urinary creatinine were measured at ICU discharge, once other organ failures had resolved. Serum creatinine was also assessed at 6 months. Non-resolving kidney dysfunction was defined as iohexol clearance < 60 mL/min/1.73 m 2 . Among 137 patients, 70 (51%) had non-resolving kidney dysfunction at ICU discharge. Among these 70 patients, urine creatinine clearance and CKD-EPI-based estimated glomerular filtration rate (GFR) were < 60 mL/min/1.73 m 2 in 69% and 19% of cases, respectively. In multivariable analysis, risk factors for non-resolving dysfunction included older age, longer ICU stay, presence of malignancy, and higher baseline and admission serum creatinine. Patients with non-resolving kidney dysfunction had significantly lower CKD-EPI GFR at 6 months compared to those with resolving dysfunction. Non-resolving kidney dysfunction was present in approximately half of patients who had experienced severe AKI despite normal serum creatinine at ICU discharge, highlighting the limitations of serum creatinine in assessing renal recovery in critically ill patients. Non-resolving dysfunction was associated with lower CKD-EPI GFR at 6 months. ClinicalTrials.gov, identifier: NCT02961478. Registered on November 11, 2016.
Language: English
Subfield: Nephrology
Field: Medicine
Open Access status: gold
Estimated APC paid: $4,190
OpenAlex ID: W7236340357
FWCI:
Cites:
Cited by:
Related to: 10